Breast cancer, aromatase inhibitors, and bone health
Aromatase inhibitors (AIs) are a first-line therapy for postmenopausal women diagnosed with estrogen receptor-positive breast cancer. Because of the estrogen…
Women with Benign Breast Disease had 70% Higher Risk of Breast Cancer than Those Without
Despite Updated Guidelines, Tests Continue and Costs Mount